Cost and Antibiotic Utilization of Pneumonia Patients in Intensive Care Unit

摘要: Article history: Received on: 16/10/2015 Revised 17/12/2015 Accepted 28/12/2015 Available online: 27/02/2016 Objective of this study is to evaluate the cost and antibiotic utilization pneumonia patients admitted in intensive care unit. It was a retrospective study. Details required for analysis were acquired from hospital files. Out 320 cases evaluated 110 pneumonia.28.2% people had as their primary diagnosis 71.8% acquired/aspiration pneumonia. The mean length ICU stay 3.30± 1.91 days. 21.8% put on ventilator. mortality rate 34.5%. Betalactum along with betalactamase inhibitor antibiotics prescribed 91% patients, Carbapenams 20%, anti-staphylococcal 51% macrolides miscellaneous 25.5% 36.4% respectively. clindamycin combination most commonly antibiotic. Average per patient who not ventilator Rs 27,123 where ventilated Rs44, 812. This showed that one third admissions due Highest numbers Cost supported two times more than non-ventilated Ventilator support expensive intervention adding followed by investigations.